159 related articles for article (PubMed ID: 33928786)
1. Micronized purified flavonoid fraction in the treatment of hemorrhoidal disease.
Godeberge P; Sheikh P; Lohsiriwat V; Jalife A; Shelygin Y
J Comp Eff Res; 2021 Jul; 10(10):801-813. PubMed ID: 33928786
[TBL] [Abstract][Full Text] [Related]
2. Micronized Purified Flavonoid Fraction in Hemorrhoid Disease: A Systematic Review and Meta-Analysis.
Sheikh P; Lohsiriwat V; Shelygin Y
Adv Ther; 2020 Jun; 37(6):2792-2812. PubMed ID: 32399811
[TBL] [Abstract][Full Text] [Related]
3. Conservative Treatment of Hemorrhoids: Results of an Observational Multicenter Study.
Zagriadskiĭ EA; Bogomazov AM; Golovko EB
Adv Ther; 2018 Nov; 35(11):1979-1992. PubMed ID: 30276625
[TBL] [Abstract][Full Text] [Related]
4. Clinical acceptability study of micronized purified flavonoid fraction 1000 mg tablets versus 500 mg tablets in patients suffering acute hemorrhoidal disease.
Shelygin Y; Krivokapic Z; Frolov SA; Kostarev IV; Astashov VL; Vasiliev SV; Lakhin AV; Rodoman GV; Soloviev AO; Stoyko YM; Khitaryan AG; Nechay IA
Curr Med Res Opin; 2016 Nov; 32(11):1821-1826. PubMed ID: 27404053
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of micronized purified flavonoid fractions for the treatment of postoperative hemorrhoid complications: A systematic review and meta-analysis.
Fu H; Guo W; Zhou B; Liu Y; Gao Y; Li M
Phytomedicine; 2022 Sep; 104():154244. PubMed ID: 35752073
[TBL] [Abstract][Full Text] [Related]
6. Recurrence Rates and Pharmacological Treatment for Hemorrhoidal Disease: A Systematic Review.
Lohsiriwat V; Sheikh P; Bandolon R; Ren DL; Roslani AC; Schaible K; Freitag A; Martin M; Yaltirik P; Godeberge P
Adv Ther; 2023 Jan; 40(1):117-132. PubMed ID: 36331754
[TBL] [Abstract][Full Text] [Related]
7. Clinical use of micronized purified flavonoid fraction for treatment of symptoms after hemorrhoidectomy: results of a randomized, controlled, clinical trial.
La Torre F; Nicolai AP
Dis Colon Rectum; 2004 May; 47(5):704-10. PubMed ID: 15037936
[TBL] [Abstract][Full Text] [Related]
8. The impact of micronized purified flavonoid fraction on the treatment of acute haemorrhoidal episodes.
Jiang ZM; Cao JD
Curr Med Res Opin; 2006 Jun; 22(6):1141-7. PubMed ID: 16846547
[TBL] [Abstract][Full Text] [Related]
9. Treatment of haemorrhoidal disease with micronized purified flavonoid fraction and sucralfate ointment.
Amaturo A; Meucci M; Mari FS
Acta Biomed; 2020 Mar; 91(1):139-141. PubMed ID: 32191669
[TBL] [Abstract][Full Text] [Related]
10. Prospective, randomized, controlled, observer-blinded trial of combined infrared photocoagulation and micronized purified flavonoid fraction versus each alone for the treatment of hemorrhoidal disease.
Dimitroulopoulos D; Tsamakidis K; Xinopoulos D; Karaitianos I; Fotopoulou A; Paraskevas E
Clin Ther; 2005 Jun; 27(6):746-54. PubMed ID: 16117981
[TBL] [Abstract][Full Text] [Related]
11. Micronized purified flavonoid fraction-based conservative treatment of chronic venous disease in a real-world setting.
Bogachev V; Boldin B; Turkin P; Samenkov A; Dzhenina O
Future Cardiol; 2022 Sep; 18(10):777-785. PubMed ID: 36004765
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of micronized purified flavonoid fractions (MPFF) for haemorrhoids: A systematic review and meta-analysis.
Aziz Z; Huin WK; Badrul Hisham MD; Tang WL; Yaacob S
Complement Ther Med; 2018 Aug; 39():49-55. PubMed ID: 30012392
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular Insights for the Appropriate Management of Chronic Venous Disease: A Narrative Review of Implications for the Use of Venoactive Drugs.
Gianesini S; De Luca L; Feodor T; Taha W; Bozkurt K; Lurie F
Adv Ther; 2023 Dec; 40(12):5137-5154. PubMed ID: 37768506
[TBL] [Abstract][Full Text] [Related]
14. Randomized clinical trial of micronized flavonoids in the early control of bleeding from acute internal haemorrhoids.
Misra MC; Parshad R
Br J Surg; 2000 Jul; 87(7):868-72. PubMed ID: 10931020
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials.
Kakkos SK; Nicolaides AN
Int Angiol; 2018 Apr; 37(2):143-154. PubMed ID: 29385792
[TBL] [Abstract][Full Text] [Related]
16. The Benefits of Micronized Purified Flavonoid Fraction (MPFF) Throughout the Progression of Chronic Venous Disease.
Nicolaides AN
Adv Ther; 2020 Feb; 37(Suppl 1):1-5. PubMed ID: 31970659
[TBL] [Abstract][Full Text] [Related]
17. Role of a Micronized Purified Flavonoid Fraction as an Adjuvant Treatment to Rubber Band Ligation for the Treatment of Patients With Hemorrhoidal Disease: A Longitudinal Cohort Study.
Caetano AC; Cunha C; Arroja B; Costa D; Rolanda C
Ann Coloproctol; 2019 Dec; 35(6):306-312. PubMed ID: 31937070
[TBL] [Abstract][Full Text] [Related]
18. Postoperative discomfort and pain in the management of hemorrhoidal disease: laser hemorrhoidoplasty, a minimal invasive treatment of symptomatic hemorrhoids.
Brusciano L; Gambardella C; Terracciano G; Gualtieri G; Schiano di Visconte M; Tolone S; Del Genio G; Docimo L
Updates Surg; 2020 Sep; 72(3):851-857. PubMed ID: 31760588
[TBL] [Abstract][Full Text] [Related]
19. Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids.
Lyseng-Williamson KA; Perry CM
Drugs; 2003; 63(1):71-100. PubMed ID: 12487623
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Centella with Flavonoids for Treatment of Symptoms in Hemorrhoidal Disease and After Surgical Intervention: A Randomized Clinical Trial.
Chiaretti M; Fegatelli DA; Pappalardo G; Venti MDS; Chiaretti AI
Sci Rep; 2020 May; 10(1):8009. PubMed ID: 32409760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
